- Home
- EMN vs BRKR Comparison
EMN vs BRKR Comparison
Compare EMN & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EMN | BRKR |
|---|---|---|
| Founded | 1920 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.0B |
| IPO Year | 1993 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EMN | BRKR |
|---|---|---|
| Price | $61.27 | $45.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $79.86 | $45.10 |
| AVG Volume (30 Days) | 1.6M | ★ 2.3M |
| Earning Date | 01-29-2026 | 11-03-2025 |
| Dividend Yield | ★ 5.49% | 0.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.01 | N/A |
| Revenue | ★ $9,024,000,000.00 | $3,438,900,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | $0.91 | $1.23 |
| P/E Ratio | $10.18 | ★ N/A |
| Revenue Growth | N/A | ★ 6.10 |
| 52 Week Low | $56.11 | $28.53 |
| 52 Week High | $103.82 | $64.64 |
Technical Indicators
Market Signals| Indicator | EMN | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 51.96 | 54.24 |
| Support Level | $60.29 | $45.37 |
| Resistance Level | $62.84 | $48.84 |
| Average True Range (ATR) | 1.84 | 1.89 |
| MACD | 0.23 | -0.38 |
| Stochastic Oscillator | 74.39 | 38.10 |
Price Performance
Historical ComparisonAbout EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.